Comparative effects of novel 5-HT(1A) receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice

Psychopharmacology

Volumn 139, Issue 3, 1998, Pages 185-194

  Cao, B J ^a   Rodgers, R J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

5 HT(1A) receptor; Anxiety; Circadian factor; Elevated plus maze; LY293284; LY297996; LY315712; Mice

Indexed keywords

(1,4 INDOLYLOXY) 3 (4 PHENYLBUTYLAMINO) 2 PROPANOL ETHANEDIOATE; (1,4 INDOLYLOXY) 3 (CYCLOHEXYLAMINO) 2 PROPANOL BUTANEDIOATE; 6 ACETYL 4 (DI N PROPYLAMINO) 1,3,4,5 TETRAHYDROBENZ[C,D]INDOLE; INDOLE DERIVATIVE; LY 293284; LY 297996; LY 315712; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION; TRANQUILIZING ACTIVITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; INDOLES; LIGANDS; MALE; MAZE LEARNING; MICE; PSYCHOMOTOR PERFORMANCE; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TRYPTAMINES;

EID: 0031702443     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050703     Document Type: Article

References (72)

1. 1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesis. Pharmacol Toxicol 72:398-406
2. 1A antagonist, on social and agonistic behaviour in male albino mice. Pharmacol Biochem Behav 46:67-72
3. Bell R, Hobson H (1993b) Effects of (-)pindolol and SDZ 216-525 on social and agonistic behaviour in mice. Pharmacol Biochem Behav 46:873-880
4. Belzung C, LePape G (1994) Comparison of different behavioural test situations used in psychopharmacology for the measurement of anxiety. Physiol Behav 56:623-628
5. 1A agonists in pigeons are dependent on the level of response suppression. Behav Pharmacol 7:540-550
6. 1A receptor antagonists (+) WAY 100135 and WAY 100635. Neuropharmacology 34:805-811
7. 1A receptor ligands in the mouse. Br J Pharmacol 111:151P
8. Bill DJ, Knight M, Forster EA, Fletcher A (1991) Direct evidence for an important species difference in the mechanism of 8-OH-DPAT hypothermia. Br J Pharmacol 103:1857-1864
9. 2receptors to inhibit firing rate of substantia nigra zona compacta cells maintained in vitro. Br J Pharmacol 99:28P
10. Cadogan AK, Kendall DA, Fink H, Marsden CA (1994) Social interaction increases 5-HT release and cAMP efflux in the rat ventral hippocampus in vivo. Behav Pharmacol 5:299-305
11. Cao B-J, Rodgers RJ (1996) Different behavioural profiles of R(+)- and S(-)-enantiomers of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the murine elevated plus-maze. Behav Pharmacol 7:810-819
12. 1A receptor antagonist, has anxiolytic-like profile in the murine elevated plus-maze. Psychopharmacology 129:365-371
13. 1A. Pharmacol Biochem Behav 58: 583-591
14. 1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN 190. Pharmacol Biochem Behav 58:593-603
15. Cao B-J, Rodgers RJ (1997d) Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze. Neuropharmacology 36: 1089-1097
16. 3) receptor antagonists increase rates of punished responding in rats. Pharmacol Biochem Behav 52:671-676
17. 1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat. Pharmacol Biochem Behav 48:281-289
18. Clement Y, Kia KH, Daval G, Verge D (1996) An autoradiographic study of serotonergic receptors in a murine genetic model of anxiety-related behaviors. Brain Res 709:229-242
19. Cole JC, Rodgers RJ (1993) An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav Pharmacol 4:573-580
20. Cole JC, Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology 114:288-296
21. 1A antagonist, WAY 100635. J Psychopharmacol 10:A46
22. Cruz APM, Frei F, Graeff FG (1994) Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49:171-176
23. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121:1-26
24. File SE (1992) Behavioural detection of anxiolytic action. In: Elliott JM, Heal DJ, Marsden CA (eds) Experimental Approaches to Anxiety and Depression. Wiley, Chichester, pp 25-44
25. 1A receptor modulation of anxiety in two ethological animals tests. J Neurosci 16:4810-4815
26. 1A receptor antagonist. Behav Brain Res 73:337-353
27. 1A receptor agonist with high potency and selectivity. J Pharmacol Exp Ther 270:1270-1281
28. 1A receptor agonists. Drug Dev Res 34:66-85
29. Fuller RW, Perry KW, Hemrick-Luecke SK, Engleman E (1996) Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus. J Pharm Pharmacol 48:68-70
30. Grewal SS, Shepherd JK, Bill DJ, Fletcher A, Dourish CT (1997) Behavioural and pharmacological characterization of the canopy stretched attend posture test as a model of anxiety in mice and rats. Psychopharmacology 133:29-38
31. Griebel G (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65:319-395
32. Griebel G, Moreau J-L, Jenck F, Martin JR, Misslin R (1993) Some critical determinants of the behaviour of rats in the elevated plus-maze. Behav Proc 29:37-48
33. Griebel G, Sanger DJ, Perrault G (1996) The use of the rat elevated plus-maze to discriminate non-selective and BZ-1(ω1) selective, benzodiazepine receptor ligands. Psychopharmacology 124:245-254
34. Griebel G, Rodgers RJ, Perrault G, Sanger DJ (1997) Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze. Pharmacol Biochem Behav 57:817-827
35. 1A antagonist is determined by arousal state. J Psychopharmacol 8:A13
36. Handley SL, McBlane JW (1993) 5-HT drugs in animal models of anxiety. Psychopharmacology 112:13-20
37. Helton DR, Rasmussen VP, Rocco JP, Tizzano JP, Kallman MJ (1995) Comparative effects of 5-hydroxytryptaminela partial agonists, full agonists, and antagonists in the murine elevated plus maze. Soc Neurosci Abstr 21:1367
38. Helton DR, Berger JE, Czachura JF, Rasmussen K, Kallman MJ (1996) Central nervous system characterization of the new cholecystokinin antagonist LY288513. Pharmacol Biochem Behav53:493-502
39. Hogg S (1996) A review of the validity and variability of the elevaled plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21-30
40. Jacobs BL, Fornal CA (1995) Serotonin and behavior. A general hypothesis. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The fourth generation of progress. Raven Press, New York, pp 461-469
41. B) receptor ligands in the elevated plus-maze test of anxiety in mice. Psychopharmacology 124: 355-364
42. 1A receptor agonists and in their inhibitory ellects on the firing of serotonergic neurons in the rat? J Pharmacol Exp Ther 272: 920-929
43. 1A receptor. Soc Neurosci Abstr 23:835.11
44. Lamberty Y, Gower AJ (1996) Arm width and brightness modulation of spontaneous behaviour of two strains of mice tested in the elevated plus-maze. Physiol Behav 59:439-444
45. 1A compounds in mice depends on the anxiety paradigm. Pharmacol Biochem Behav 54:677-686
46. 1A agonists. Behav Pharmacol 5:42-51
47. 7) implicated in the regulation of mammalian circadian rhythms. Neuron 11:449-458
48. 1A receptors to 8-OH-DPAT in rats. Psychopharmacology 123:42-45
49. 1A receptors is endogenous in nature. Cell Mol Life Sci 53:224-226
50. 1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology 125: 89-91
51. 1A receptor. Nature 267:289-290
52. 1A receptor antagonist (S)-UH-301 in rodents and monkeys. Brain Res Bull 29:901-904
53. Moser PC, Redfern PH (1985) Circadian variation in behavioural responses to central 5-HT receptor stimulation in the mouse. Psychopharmacology 86:23-227
54. Nagayama H (1993) Chronopharmacology of psychotropic drugs: circadian rhythms in drug effects and its implications to rhythms in the brain. Pharmacol Ther 59:31-54
55. Njung'e K, Critchley MAE, Handley SL (1993) Effects of beta-adrenoceptor ligands in the elevated X-maze "anxiety" model and antagonism of the "anxiogenic" response to 8-OH-DPAT. J Psychopharmacol 7:173-180
56. 1A) receptors in the anticonflict activity of β-adrenoceptor antagonists. Pharmacol Biochem Behav 47:873-878
57. 1A) receptors in the anticonflict activity of β-adrenoceptor antagonists. Neuropharmacology 34:1211-1217
58. Ramos A, Berton O, Mormede P, Chaouloff F (1997) A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 85:57-69
59. Rodgers RJ (1997) Animal models of anxiety: where next? Behav Pharmacol 8:477-496
60. Rodgers RJ, Cole JC (1994a) The elevated plus-maze: pharmacology, methodology and ethology. In: Cooper SJ, Hendrie CA (eds) Ethology and psychopharmacology. Wiley, Chichester, pp 9-44
61. 1A receptor antagonist, in the murine elevated plus-maze test. Eur J Pharmacol 261:321-325
62. Rodgers RJ, Johnson NJT (1995) Factor analysis of spatiotemporal and ethological measures in the elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52:297-303
63. Rodgers RJ, Cole JC, Cobain MR, Daly P, Doran PJ, Eells JR, Wallis P (1992) Anxiogenic-like effects of fluprazine and etoprazine in the mouse elevated plus-maze: prolile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behav Pharmacol 3:621-634
64. Rodgers RJ, Cao B-J, Dalvi A, Holmes A (1997) Animal models of anxiety; an ethological perspective. Braz J Med Biol Res 30:298-304
65. Sanchez C (1993) Effects of serotonergic drugs on foolshock-induced ultrasonic vocalization in adult male rats. Behav Pharmacol 4:269-277
66. Sanchez C (1995) Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white test box. Pharmacol Toxicol 77: 71-78
67. 1A receptors play an important role in modulation of behaviour of rats in a two-compartment black and white box. Behav Pharmacol 7:788-797
68. Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994) Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology 116:56-64
69. 1A receptor agonists, partial agonists and a silent antagonist on the performance of the conditioned emotional response test in the rat. Psychopharmacology 128:293-303
70. Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463-469
71. 1A receptor ligands by drug discrimination. Eur J Pharmacol 333: 113-122
72. 1A receptor. Soc Neurosci Abstr 20:663.6